The company said third-quarter net sales of $5.0 billion were down 4%, with foreign currency translation reducing sales by about 3% and the divestiture of the PPE business by about 1%, while organic sales grew 1%.

1. 01

   The company said third-quarter net sales of $5.0 billion were down 4%, with foreign currency translation reducing sales by about 3% and the divestiture of the PPE business by about 1%, while organic sales grew 1%.

2. 02

   The company said third-quarter operating profit was $1.2 billion, including $565 million in gains from the sale of the PPE business, and that adjusted operating profit rose 5%.

3. 03

   The company said third-quarter diluted earnings per share were $2.69, including a $1.34 increase from the sale of the PPE business, a $0.31 decrease from Transformation Initiative costs and a $0.17 decrease from impairment of intangible assets. It said adjusted earnings per share were $1.83. Q3

4. 04

   The company said operating cash flow for the first 9 months of the year was $2.4 billion, and that it returned $2.0 billion to shareholders through dividends and share repurchases. It also said total debt was $7.5 billion as of September 30, 2024.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.